Zulvac 8 Bovis

RSS

inactivated bluetongue virus, serotype 8

Withdrawn
This medicine is now withdrawn from use in the European Union.

Overview

The marketing authorisation for this product has been withdrawn at the request of the marketing authorisation holder.

This EPAR was last updated on 24/11/2020

Authorisation details

Product details
Name
Zulvac 8 Bovis
Agency product number
EMEA/V/C/000145
Active substance
inactivated bluetongue virus, serotype 8, strain btv-8/bel2006/02
International non-proprietary name (INN) or common name
inactivated bluetongue virus, serotype 8
Species
Cattle
Anatomical therapeutic chemical veterinary (ATCvet) codes
QI02AA08
Publication details
Marketing-authorisation holder
Zoetis Belgium
Revision
7
Date of issue of marketing authorisation valid throughout the European Union
15/01/2010
Contact address

Zoetis Belgium
Rue Laid Burniat 1
1348 Louvain-la-Neuve
Belgium

Product information

23/03/2017 Zulvac 8 Bovis - EMEA/V/C/000145 - IG/0747

Other EU languages available icon This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.

 

Product information documents contain:

  • summary of product characteristics (annex I);
  • manufacturing authorisation holder responsible for batch release (annex IIA);
  • conditions of the marketing authorisation (annex IIB);
  • labelling (annex IIIA);
  • package leaflet (annex IIIB).

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

Immunologicals

Therapeutic indication

Active immunisation of cattle from three months of age for the prevention of viraemia caused by bluetongue virus, serotype 8.

Assessment history

News

How useful was this page?

Add your rating